Selected research
Industry Growth & Trends
Global Epirubicin Hydrochloride Industry Growth and Trends Forecast to 2032
Market perspective
The global Epirubicin Hydrochloride market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Epirubicin Hydrochloride is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Epirubicin Hydrochloride is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Epirubicin Hydrochloride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Epirubicin Hydrochloride include Flavine, Humble Healthcaare, Intas Pharma, Microbiopharm Japan, Sterling Biotech, Synbias Pharma, Teva API, Beijing Union Pharmaceutical Factory and DZD Heze Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Epirubicin Hydrochloride market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Epirubicin Hydrochloride market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Epirubicin Hydrochloride market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Epirubicin Hydrochloride.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Epirubicin Hydrochloride market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Epirubicin Hydrochloride Market by Company
Flavine
Humble Healthcaare
Intas Pharma
Microbiopharm Japan
Sterling Biotech
Synbias Pharma
Teva API
Beijing Union Pharmaceutical Factory
DZD Heze Pharma
Pfizer
Lunan Pharmaceutical Group
Zhejiang Hisun Pharma
Epirubicin Hydrochloride Segment by Type
10mg/5ml
50mg/25ml
Other
Epirubicin Hydrochloride Segment by Application
Cancer
Others
Epirubicin Hydrochloride Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Epirubicin Hydrochloride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Epirubicin Hydrochloride and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Epirubicin Hydrochloride.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Epirubicin Hydrochloride manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Epirubicin Hydrochloride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 10mg/5ml
- 50mg/25ml
- Other
Applications
- Cancer
- Others
Companies covered
- Flavine
- Humble Healthcaare
- Intas Pharma
- Microbiopharm Japan
- Sterling Biotech
- Synbias Pharma
- Teva API
- Beijing Union Pharmaceutical Factory
- DZD Heze Pharma
- Pfizer
- Lunan Pharmaceutical Group
- Zhejiang Hisun Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Epirubicin Hydrochloride Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Epirubicin Hydrochloride Sales Estimates and Forecasts (2021-2032)
- 1.3 Epirubicin Hydrochloride Market by Type
- 1.3.1 10mg/5ml
- 1.3.2 50mg/25ml
- 1.3.3 Other
- 1.4 Global Epirubicin Hydrochloride Market Size by Type
- 1.4.1 Global Epirubicin Hydrochloride Market Size Overview by Type (2021-2032)
- 1.4.2 Global Epirubicin Hydrochloride Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Epirubicin Hydrochloride Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Epirubicin Hydrochloride Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Epirubicin Hydrochloride Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Epirubicin Hydrochloride Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Epirubicin Hydrochloride Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Epirubicin Hydrochloride Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Epirubicin Hydrochloride Industry Trends
- 2.2 Epirubicin Hydrochloride Industry Drivers
- 2.3 Epirubicin Hydrochloride Industry Opportunities and Challenges
- 2.4 Epirubicin Hydrochloride Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Epirubicin Hydrochloride Revenue (2021-2026)
- 3.2 Global Top Players by Epirubicin Hydrochloride Sales (2021-2026)
- 3.3 Global Top Players by Epirubicin Hydrochloride Price (2021-2026)
- 3.4 Global Epirubicin Hydrochloride Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Epirubicin Hydrochloride Major Company Production Sites & Headquarters
- 3.6 Global Epirubicin Hydrochloride Company, Product Type & Application
- 3.7 Global Epirubicin Hydrochloride Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Epirubicin Hydrochloride Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Epirubicin Hydrochloride Players Market Share by Revenue in 2025
- 3.8.3 2025 Epirubicin Hydrochloride Tier 1, Tier 2, and Tier 3
4 Epirubicin Hydrochloride Regional Status and Outlook
- 4.1 Global Epirubicin Hydrochloride Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Epirubicin Hydrochloride Historic Market Size by Region
- 4.2.1 Global Epirubicin Hydrochloride Sales in Volume by Region (2021-2026)
- 4.2.2 Global Epirubicin Hydrochloride Sales in Value by Region (2021-2026)
- 4.2.3 Global Epirubicin Hydrochloride Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Epirubicin Hydrochloride Forecasted Market Size by Region
- 4.3.1 Global Epirubicin Hydrochloride Sales in Volume by Region (2027-2032)
- 4.3.2 Global Epirubicin Hydrochloride Sales in Value by Region (2027-2032)
- 4.3.3 Global Epirubicin Hydrochloride Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Epirubicin Hydrochloride by Application
- 5.1 Epirubicin Hydrochloride Market by Application
- 5.1.1 Cancer
- 5.1.2 Others
- 5.2 Global Epirubicin Hydrochloride Market Size by Application
- 5.2.1 Global Epirubicin Hydrochloride Market Size Overview by Application (2021-2032)
- 5.2.2 Global Epirubicin Hydrochloride Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Epirubicin Hydrochloride Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Epirubicin Hydrochloride Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Epirubicin Hydrochloride Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Epirubicin Hydrochloride Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Epirubicin Hydrochloride Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Epirubicin Hydrochloride Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Flavine
- 6.1.1 Flavine Company Information
- 6.1.2 Flavine Business Overview
- 6.1.3 Flavine Epirubicin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Flavine Epirubicin Hydrochloride Product Portfolio
- 6.1.5 Flavine Recent Developments
- 6.2 Humble Healthcaare
- 6.2.1 Humble Healthcaare Company Information
- 6.2.2 Humble Healthcaare Business Overview
- 6.2.3 Humble Healthcaare Epirubicin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Humble Healthcaare Epirubicin Hydrochloride Product Portfolio
- 6.2.5 Humble Healthcaare Recent Developments
- 6.3 Intas Pharma
- 6.3.1 Intas Pharma Company Information
- 6.3.2 Intas Pharma Business Overview
- 6.3.3 Intas Pharma Epirubicin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Intas Pharma Epirubicin Hydrochloride Product Portfolio
- 6.3.5 Intas Pharma Recent Developments
- 6.4 Microbiopharm Japan
- 6.4.1 Microbiopharm Japan Company Information
- 6.4.2 Microbiopharm Japan Business Overview
- 6.4.3 Microbiopharm Japan Epirubicin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Microbiopharm Japan Epirubicin Hydrochloride Product Portfolio
- 6.4.5 Microbiopharm Japan Recent Developments
- 6.5 Sterling Biotech
- 6.5.1 Sterling Biotech Company Information
- 6.5.2 Sterling Biotech Business Overview
- 6.5.3 Sterling Biotech Epirubicin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Sterling Biotech Epirubicin Hydrochloride Product Portfolio
- 6.5.5 Sterling Biotech Recent Developments
- 6.6 Synbias Pharma
- 6.6.1 Synbias Pharma Company Information
- 6.6.2 Synbias Pharma Business Overview
- 6.6.3 Synbias Pharma Epirubicin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Synbias Pharma Epirubicin Hydrochloride Product Portfolio
- 6.6.5 Synbias Pharma Recent Developments
- 6.7 Teva API
- 6.7.1 Teva API Company Information
- 6.7.2 Teva API Business Overview
- 6.7.3 Teva API Epirubicin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Teva API Epirubicin Hydrochloride Product Portfolio
- 6.7.5 Teva API Recent Developments
- 6.8 Beijing Union Pharmaceutical Factory
- 6.8.1 Beijing Union Pharmaceutical Factory Company Information
- 6.8.2 Beijing Union Pharmaceutical Factory Business Overview
- 6.8.3 Beijing Union Pharmaceutical Factory Epirubicin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Beijing Union Pharmaceutical Factory Epirubicin Hydrochloride Product Portfolio
- 6.8.5 Beijing Union Pharmaceutical Factory Recent Developments
- 6.9 DZD Heze Pharma
- 6.9.1 DZD Heze Pharma Company Information
- 6.9.2 DZD Heze Pharma Business Overview
- 6.9.3 DZD Heze Pharma Epirubicin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 DZD Heze Pharma Epirubicin Hydrochloride Product Portfolio
- 6.9.5 DZD Heze Pharma Recent Developments
- 6.10 Pfizer
- 6.10.1 Pfizer Company Information
- 6.10.2 Pfizer Business Overview
- 6.10.3 Pfizer Epirubicin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Pfizer Epirubicin Hydrochloride Product Portfolio
- 6.10.5 Pfizer Recent Developments
- 6.11 Lunan Pharmaceutical Group
- 6.11.1 Lunan Pharmaceutical Group Company Information
- 6.11.2 Lunan Pharmaceutical Group Business Overview
- 6.11.3 Lunan Pharmaceutical Group Epirubicin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Lunan Pharmaceutical Group Epirubicin Hydrochloride Product Portfolio
- 6.11.5 Lunan Pharmaceutical Group Recent Developments
- 6.12 Zhejiang Hisun Pharma
- 6.12.1 Zhejiang Hisun Pharma Company Information
- 6.12.2 Zhejiang Hisun Pharma Business Overview
- 6.12.3 Zhejiang Hisun Pharma Epirubicin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Zhejiang Hisun Pharma Epirubicin Hydrochloride Product Portfolio
- 6.12.5 Zhejiang Hisun Pharma Recent Developments
7 North America by Country
- 7.1 North America Epirubicin Hydrochloride Sales by Country
- 7.1.1 North America Epirubicin Hydrochloride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Epirubicin Hydrochloride Sales by Country (2021-2026)
- 7.1.3 North America Epirubicin Hydrochloride Sales Forecast by Country (2027-2032)
- 7.2 North America Epirubicin Hydrochloride Market Size by Country
- 7.2.1 North America Epirubicin Hydrochloride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Epirubicin Hydrochloride Market Size by Country (2021-2026)
- 7.2.3 North America Epirubicin Hydrochloride Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Epirubicin Hydrochloride Sales by Country
- 8.1.1 Europe Epirubicin Hydrochloride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Epirubicin Hydrochloride Sales by Country (2021-2026)
- 8.1.3 Europe Epirubicin Hydrochloride Sales Forecast by Country (2027-2032)
- 8.2 Europe Epirubicin Hydrochloride Market Size by Country
- 8.2.1 Europe Epirubicin Hydrochloride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Epirubicin Hydrochloride Market Size by Country (2021-2026)
- 8.2.3 Europe Epirubicin Hydrochloride Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Epirubicin Hydrochloride Sales by Country
- 9.1.1 Asia-Pacific Epirubicin Hydrochloride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Epirubicin Hydrochloride Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Epirubicin Hydrochloride Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Epirubicin Hydrochloride Market Size by Country
- 9.2.1 Asia-Pacific Epirubicin Hydrochloride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Epirubicin Hydrochloride Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Epirubicin Hydrochloride Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Epirubicin Hydrochloride Sales by Country
- 10.1.1 South America Epirubicin Hydrochloride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Epirubicin Hydrochloride Sales by Country (2021-2026)
- 10.1.3 South America Epirubicin Hydrochloride Sales Forecast by Country (2027-2032)
- 10.2 South America Epirubicin Hydrochloride Market Size by Country
- 10.2.1 South America Epirubicin Hydrochloride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Epirubicin Hydrochloride Market Size by Country (2021-2026)
- 10.2.3 South America Epirubicin Hydrochloride Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Epirubicin Hydrochloride Sales by Country
- 11.1.1 Middle East and Africa Epirubicin Hydrochloride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Epirubicin Hydrochloride Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Epirubicin Hydrochloride Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Epirubicin Hydrochloride Market Size by Country
- 11.2.1 Middle East and Africa Epirubicin Hydrochloride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Epirubicin Hydrochloride Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Epirubicin Hydrochloride Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Epirubicin Hydrochloride Value Chain Analysis
- 12.1.1 Epirubicin Hydrochloride Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Epirubicin Hydrochloride Production Mode & Process
- 12.2 Epirubicin Hydrochloride Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Epirubicin Hydrochloride Distributors
- 12.2.3 Epirubicin Hydrochloride Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst